Gestational hypothyroxinemia induces ASD-like phenotypes in behavior, proinflammatory markers, and glutamatergic protein expression in mouse offspring of both sexes

dc.contributor.affiliationUniversidad Andres Bello
dc.contributor.affiliationPontificia Universidad Catolica de Chile
dc.contributor.affiliationUniversidad de Las Americas - Chile
dc.contributor.affiliationUniversidad Autonoma de Chile
dc.contributor.authorGonzález-Madrid, Enrique
dc.contributor.authorRangel-Ramírez, Ma. Andreina
dc.contributor.authorOpazo, Maria C.
dc.contributor.authorMéndez, Luis
dc.contributor.authorBohmwald, Karen
dc.contributor.authorBueno, Susan M.
dc.contributor.authorGonzalez, Pablo A.
dc.contributor.authorKalergis, Alexis M.
dc.contributor.authorRiedel, Claudia A.
dc.date.accessioned2025-04-22T19:59:03Z
dc.date.available2025-04-22T19:59:03Z
dc.date.issued2024-05-01
dc.description.abstractBackground The prevalence of autism spectrum disorder (ASD) has significantly risen in the past three decades, prompting researchers to explore the potential contributions of environmental factors during pregnancy to ASD development. One such factor of interest is gestational hypothyroxinemia (HTX), a frequent condition in pregnancy associated with cognitive impairments in the offspring. While retrospective human studies have linked gestational HTX to autistic traits, the cellular and molecular mechanisms underlying the development of ASD-like phenotypes remain poorly understood. This study used a mouse model of gestational HTX to evaluate ASD-like phenotypes in the offspring. Methods To induce gestational HTX, pregnant mice were treated with 2-mercapto-1-methylimidazole (MMI), a thyroid hormones synthesis inhibitor, in the tap-drinking water from embryonic days (E) 10 to E14. A separate group received MMI along with a daily subcutaneous injection of T 4 , while the control group received regular tap water during the entire pregnancy. Female and male offspring underwent assessments for repetitive, anxious, and social behaviors from postnatal day (P) 55 to P64. On P65, mice were euthanized for the evaluation of ASD-related inflammatory markers in blood, spleen, and specific brain regions. Additionally, the expression of glutamatergic proteins (NLGN3 and HOMER1) was analyzed in the prefrontal cortex and hippocampus. Results The HTX-offspring exhibited anxious-like behavior, a subordinate state, and impaired social interactions. Subsequently, both female and male HTX-offspring displayed elevated proinflammatory cytokines in blood, including IL-1β, IL-6, IL-17A, and TNF-α, while only males showed reduced levels of IL-10. The spleen of HTX-offspring of both sexes showed increased Th17/Treg ratio and M1-like macrophages. In the prefrontal cortex and hippocampus of male HTX-offspring, elevated levels of IL-17A and reduced IL-10 were observed, accompanied by increased expression of hippocampal NLGN3 and HOMER1. All these observations were compared to those observed in the Control-offspring. Notably, the supplementation with T 4 during the MMI treatment prevents the development of the observed phenotypes. Correlation analysis revealed an association between maternal T 4 levels and specific ASD-like outcomes. Discussion This study validates human observations, demonstrating for the first time that gestational HTX induces ASD-like phenotypes in the offspring, highlighting the need of monitoring thyroid function during pregnancy.
dc.description.sponsorshipAgencia Nacional de Investigacin y Desarrollo10.13039/501100020884; Millennium Institute on Immunology and Immunotherapy (IMII); We thank LM for all administrative and technical support in performing this work and the Millennium Institute on Immunology and Immunotherapy (IMII) for support.
dc.format.mimetypeapplication/pdf
dc.identifier.citationFrontiers in Endocrinology, 15, 1381180. https://doi.org/10.3389/fendo.2024.1381180
dc.identifier.doihttps://doi.org/10.3389/fendo.2024.1381180
dc.identifier.folio1231851
dc.identifier.folio1240971
dc.identifier.folio1231905
dc.identifier.folio11221280
dc.identifier.folio1191300
dc.identifier.folio21202085
dc.identifier.issn1664-2392
dc.identifier.orcidhttps://orcid.org/0000-0003-0257-6751
dc.identifier.orcidhttps://orcid.org/0009-0003-9827-9790
dc.identifier.orcidhttps://orcid.org/0000-0003-1004-451X
dc.identifier.pmid38752179
dc.identifier.researcheridHOH-2917-2023
dc.identifier.researcheridNQF-1632-2025
dc.identifier.researcheridJBJ-8478-2023
dc.identifier.researcheridAAF-2934-2021
dc.identifier.researcheridKSL-5357-2024
dc.identifier.researcheridL-1973-2013
dc.identifier.rorhttps://ror.org/01qq57711
dc.identifier.rorhttps://ror.org/04teye511
dc.identifier.rorhttps://ror.org/05j6ybs54
dc.identifier.rorhttps://ror.org/010r9dy59
dc.identifier.rorhttps://ror.org/0166e9x11
dc.identifier.scopusauthorid57761948400
dc.identifier.scopusauthorid57762422100
dc.identifier.scopusauthorid55966517500
dc.identifier.scopusauthorid57209108544
dc.identifier.scopusauthorid40260992400
dc.identifier.scopusauthorid7003686736
dc.identifier.scopusauthorid57206413101
dc.identifier.scopusauthorid6601943684
dc.identifier.scopusauthorid24764954100
dc.identifier.urihttps://repositorio.udla.cl/handle/udla/1774
dc.language.isoeng
dc.publisherFRONTIERS MEDIA SA
dc.relation.fundingUniversidad de Chile, Uchile, (21202085, PUENTE-2023-18)
dc.relation.fundingUniversidad de Chile, Uchile
dc.relation.fundingFondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT, (1231851, 1240971, 1231905, 11221280, 1191300)
dc.relation.fundingFondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT
dc.relation.fundingAgencia Nacional de Investigación y Desarrollo, ANID, (ICN2021_045)
dc.relation.fundingAgencia Nacional de Investigación y Desarrollo, ANID
dc.relation.fundingAgencia Nacional de Investigacin y Desarrollo10.13039/501100020884
dc.relation.fundingMillennium Institute on Immunology and Immunotherapy (IMII)
dc.relation.isindexedbyWeb of Science
dc.relation.issn1664-2392
dc.rightsCreative Commons Attribution 4.0 International
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceFRONTIERS IN ENDOCRINOLOGY
dc.source.urihttps://doi.org/10.3389/fendo.2024.1381180
dc.subjectprenatal thyroid function
dc.subjectgestational hypothyroxinemia
dc.subjectneurodevelopment
dc.subjectautism spectrum disorder
dc.subjectbehavior
dc.subjectinflammation
dc.subjectNLGN3 and HOMER1 expression
dc.subject.lcshAutismo
dc.subject.lcshTrastornos del espectro autista en niños
dc.subject.oecd13 Ciencias Médicas y de la Salud
dc.subject.oecd23.2 Medicina Clínica
dc.subject.oecd33.2.18 Endocrinología y Metabolismo
dc.titleGestational hypothyroxinemia induces ASD-like phenotypes in behavior, proinflammatory markers, and glutamatergic protein expression in mouse offspring of both sexes
dc.title.alternativeGestational hypothyroxinemia induces ASD-like phenotypes in behavior, proinflammatory markers, and glutamatergic protein expression in mouse offspring of both sexes.
dc.typejournal article
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
oaire.citation.titleFRONTIERS IN ENDOCRINOLOGY
oaire.citation.volume15
oaire.fundingReference.awardNumber1231851
oaire.fundingReference.awardNumber1240971
oaire.fundingReference.awardNumber1231905
oaire.fundingReference.awardNumber11221280
oaire.fundingReference.awardNumber1191300
oaire.fundingReference.awardNumber21202085
oaire.fundingReference.funderNameAgencia Nacional de Investigación y Desarrollo (ANID)
udla.curacion.controljmvg
udla.oecd.area3 Ciencias Médicas y de la Salud
udla.oecd.discipline3.2.18 Endocrinología y Metabolismo
udla.oecd.subarea3.2 Medicina Clínica

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
086-Gestational hypothyroxinemia.pdf
Size:
22.26 MB
Format:
Adobe Portable Document Format
Description:
Artículo

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections